Carlo Salvarani

Research interests

Publications

• Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis

  Frontiers in Pharmacology · 2019 · 10.3389/fphar.2018.01526

• EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

  Annals of the Rheumatic Diseases · 2018 · https://doi.org/10.1136/annrheumdis-2017-212649

• 2018 update of the EULAR recommendations for the management of Behçet's syndrome

  Annals of the Rheumatic Diseases · 2018 · 10.1136/annrheumdis-2018-213225

• Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

  Annals of the Rheumatic Diseases · 2018 · 10.1136/annrheumdis-2018-213328

• Trial of Tocilizumab in Giant-Cell Arteritis

  New England Journal of Medicine · 2017 · 10.1056/nejmoa1613849

• 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

  Annals of the Rheumatic Diseases · 2015 · 10.1136/annrheumdis-2015-207492

• 2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative

  Arthritis & Rheumatology · 2015 · 10.1002/art.39333

• Large-vessel giant cell arteritis: a cohort study

  Lara D. Veeken · 2014 · 10.1093/rheumatology/keu329

• The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria

  Journal of the European Academy of Dermatology and Venereology · 2013 · 10.1111/jdv.12107

• Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations

  Journal of Neurology · 2013 · 10.1007/s00415-013-7209-3

• 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

  Annals of the Rheumatic Diseases · 2012 · 10.1136/annrheumdis-2011-200329

• Adult primary central nervous system vasculitis

  The Lancet · 2012 · 10.1016/s0140-6736(12)60069-5

• 2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative

  Arthritis & Rheumatism · 2012 · 10.1002/art.34356

• Giant Cell Arteritis and Polymyalgia Rheumatica

  · 2009 · 10.1007/978-1-84800-934-9_27

• EULAR recommendations for the management of large vessel vasculitis

  Annals of the Rheumatic Diseases · 2008 · https://doi.org/10.1136/ard.2008.088351

• EULAR recommendations for the management of Behçet disease

  Annals of the Rheumatic Diseases · 2008 · 10.1136/ard.2007.080432

• Polymyalgia rheumatica and giant-cell arteritis

  The Lancet · 2008 · 10.1016/s0140-6736(08)61077-6

• EULAR recommendations for the management of primary small and medium vessel vasculitis

  Annals of the Rheumatic Diseases · 2008 · https://doi.org/10.1136/ard.2008.088096

• Primary central nervous system vasculitis: analysis of 101 patients

  Annals of Neurology · 2007 · 10.1002/ana.21226

• Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.

  PubMed · 2007 · 10.7326/0003-4819-146-9-200705010-00004

• Retroperitoneal fibrosis

  The Lancet · 2006 · 10.1016/s0140-6736(06)68035-5

• Takayasu's arteritis: A study of 104 Italian patients

  Arthritis Care & Research · 2005 · 10.1002/art.20922

• Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

  Annals of the Rheumatic Diseases · 2004 · https://doi.org/10.1136/ard.2004.020875

• Polymyalgia Rheumatica and Giant-Cell Arteritis

  New England Journal of Medicine · 2002 · 10.1056/nejmra011913

• The Incidence of Giant Cell Arteritis in Olmsted County, Minnesota: Apparent Fluctuations in a Cyclic Pattern

  Annals of Internal Medicine · 1995 · 10.7326/0003-4819-123-3-199508010-00006

Current projects

No projects listed.